Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07610005 · ClinicalTrials.gov registry record · Phase 1
A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants
A Phase 1 study, sponsored by Immunome.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT07610005: Recruiting Phase 1 study, sponsored by Immunome.
NCT07610005 is a Phase 1 study that is actively recruiting participants, run by Immunome. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07610005, a Phase 1 study, is actively recruiting participants, sponsored by Immunome.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is an open-label, randomized, crossover study to evaluate the relative bioavailability (rBA) and bioequivalence (BE) of a test capsule formulation of varegacestat compared to reference capsules formulation under fasting conditions.
Interventions
- DRUG Varegacestat Reference Formulation
- DRUG Varegacestat Test Formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05-21 |
| Est. Completion | 2026-06 |
| Phase | Phase 1 |
What NCT07610005 shows while recruiting
NCT07610005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Varegacestat Reference Formulation is the first listed.
NCT07610005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07610005 about?
NCT07610005 is a clinical study titled "A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants". This is an open-label, randomized, crossover study to evaluate the relative bioavailability (rBA) and bioequivalence (BE) of a test capsule formulation of varegacestat compared to reference capsules formulation under fasting conditions.
What is the current status of trial NCT07610005?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-05-21. Estimated completion is 2026-06.
What interventions are being tested in trial NCT07610005?
The interventions under investigation include: Varegacestat Reference Formulation (DRUG), Varegacestat Test Formulation (DRUG).
Who is sponsoring clinical trial NCT07610005?
This trial is sponsored by Immunome, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07610005's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI